Research map: Lipid-based nanocarrier-enabled combination therapy for breast cancer: overcoming drug resistance toward precision oncology

Back to the article

Papers in this map

  1. Doxil® — The first FDA-approved nano-drug: Lessons learned · Yechezkel Barenholz · 2012 · 4757 citations · Cited by this paper
  2. Apoptosis-inducing potential of tilorone dihydrochloride in triple-negative breast cancer: in silico and in vitro evidences · 2026 · Related
  3. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics · Uttpal Anand · 2022 · 1817 citations · Cited by this paper
  4. EPA-loaded silica nanoemulsions attenuate DEN-induced hepatic fibroinflammation by modulating homocysteine, PKCα/NF-κB, and Nrf2 signaling · 2026 · Related
  5. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability · Linde Schoenmaker · 2021 · 1573 citations · Cited by this paper
  6. Cycloastragenol overcomes trastuzumab resistance in HER2-positive breast cancer by regulating cell cycle and epithelial-mesenchymal transition through EZH2/PTEN/AKT pathway · 2026 · Related
  7. Targeted drug delivery strategies for precision medicines · Mandana T. Manzari · 2021 · 1181 citations · Cited by this paper
  8. Exploring betanin regulatory impact on TGF-β and PI3K/AKT pathways in oral cancer · 2026 · Related
  9. Exploring treatment options in cancer: tumor treatment strategies · Beilei Liu · 2024 · 1147 citations · Cited by this paper
  10. The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted Therapies · 2025 · Related
  11. Smart nanoparticles for cancer therapy · Leming Sun · 2023 · 1035 citations · Cited by this paper
  12. Myrtenol modulates TWEAK/TLR4–NF-κB, miR-21, PTEN, and ERK-1 expressions and improves behavioral outcomes in a rat glioblastoma model · 2026 · Related
  13. Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer · Gerald Batist · 2001 · 669 citations · Cited by this paper
  14. Protective effects of ginseng against reproductive injury: mechanisms and research progress · 2026 · Related
  15. Cancer biomarkers: Emerging trends and clinical implications for personalized treatment · Antonio Passaro · 2024 · 663 citations · Cited by this paper
  16. Development of citrinin-loaded liposomes and in vitro toxicogenetic evaluation on breast cells · 2026 · Related
  17. Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches · Talha Bin Emran · 2022 · 596 citations · Cited by this paper
  18. Luteolin alleviates inflammation by inhibiting the PI3K-Akt-FOXO3a pathway · 2026 · Related
  19. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance · Shujing Wang · 2024 · 563 citations · Cited by this paper
  20. Neurocognitive Dysfunction (‘Chemo Brain’) in Breast Cancer Survivors: Mechanisms and Emerging Therapeutic Strategies · 2026 · Related
  21. Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine · Jeffrey Alan Silverman · 2012 · 472 citations · Cited by this paper
  22. Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies · Alessia Anna Catalano · 2022 · 466 citations · Cited by this paper
  23. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group · Maria Fernanda Mosele · 2024 · 409 citations · Cited by this paper
  24. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives · Zehra Edis · 2021 · 391 citations · Cited by this paper
  25. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance · Christiana Michael Neophytou · 2021 · 377 citations · Cited by this paper
  26. Understanding and targeting resistance mechanisms in cancer · Zi‐Ning Lei · 2023 · 341 citations · Cited by this paper
  27. Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells · Pankaj Kumar Garg · 2024 · 327 citations · Cited by this paper
  28. Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies · Mihaela D. Aldea · 2021 · 323 citations · Cited by this paper
  29. Clinical trial design in the era of precision medicine · Elena Fountzilas · 2022 · 310 citations · Cited by this paper
  30. Targeting epigenetic regulators to overcome drug resistance in cancers · Nan Wang · 2023 · 310 citations · Cited by this paper
  31. New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy · Alberto Gabizón · 2016 · 264 citations · Cited by this paper
  32. Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance · Huan Xiao · 2021 · 261 citations · Cited by this paper
  33. Targeting Akt in cancer for precision therapy · Hui Ming Hua · 2021 · 251 citations · Cited by this paper
  34. Targeting Drug Chemo-Resistance in Cancer Using Natural Products · Wamidh H. Talib · 2021 · 233 citations · Cited by this paper
  35. Lipoplatin Formulation Review Article · George P. Stathopoulos · 2011 · 222 citations · Cited by this paper
  36. (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy · Milad Ashrafizadeh · 2023 · 204 citations · Cited by this paper
  37. Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery · Hussein Sabit · 2025 · 204 citations · Cited by this paper
  38. Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance? · Marta Szumilak · 2021 · 197 citations · Cited by this paper
  39. Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology · Jing‐Jing Yang · 2022 · 191 citations · Cited by this paper

Source: OpenAlex (CC0)